Araujo-Castro, M, Biagetti, B, Menéndez, E, Novoa-Testa, I, Cordido, F, Berrocal, VR, Pascual-Corrales, E, Guerrero-Pérez, F, Vicente, A, García-Centeno, R, Gonzalez, L, Garcia, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Alvarez-Escola, C, Jimenez, CT, Abellan-Galiana, P, Venegas, E, González-Molero, I, Iglesias, P, Blanco, C, De Lara, FVO, Novoa, MPD, Torres, ELM, Hanzu, F, Lamas, C, Rodriguez, SA, Aulinas, A, Recio, JM, Aviles-Pérez, MD, Núñez, MAS, Camara, R, Fano, MP, Fajardo, C, Cardoso, L, Marques, P, Martínez-Sàez, E, Ruz-Caracuel, I, Marazuela, M, Puig-Domingo, M. Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas. Endocrine Connections. 2025; 14(7)DOI:10.1530/EC-25-0103. PMID:40590355. IF:2.800(Q3/6D).

Villamarín , M, Fernández-Hidalgo, N, Escolà-Vergé, L. Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre-a counterpoint. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2025; 80(7)DOI:10.1093/jac/dkaf164. PMID:40396694. IF:3.600(Q2/3D).

Mosnaim, GS, Price, D, Côté, A, Plaza, V, Xia, CM, Awad, H, Kwah, J. DUPILUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AND ASTHMA CONTROL IN PATIENTS WITH AND WITHOUT COEXISTING TYPE 2 CONDITIONS: RESULTS FROM THE RAPID STUDY. VALUE IN HEALTH. 2025; 28(6)DOI:. PMID:. IF:6.000(Q1/1D).

Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Esteban, H, Gil, P, de Miguel, M, Alejos, B, Martínez, E. Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial. Lancet HIV. 2025; 12(7)DOI:10.1016/S2352-3018(25)00105-5. PMID:40489982. IF:13.000(Q1/1D).

Uyar, GC, Mirallas, O, Baskurt, K, Martin-Cullell, B, Yesilbas, E, Recuero-Borau, J, Kaya, S, Garcés, VN, Yücel, SE, Cano, KSV, Gómez-Puerto, D, Gómez, AP, de Torres, CS, Öksüzoglu, ÖBÇ, Serradell, S, Dienstmann, R, Sutcuoglu, O. Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores. Lancet Regional Health-Europe. 2025; 54DOI:10.1016/j.lanepe.2025.101317. PMID:40672056. IF:13.000(Q1/1D).

Cappuzzo, F, Zvirbule, Z, Korbenfeld, E, Kolb-Sielecki, J, Isla, D, Szczesna, A, Sanchez, AYC, Bustillos, A, Liu, XY, Young, F, Tosti, N, Monteiro, MF, Majem, M. Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC (vol 6, 100815, 2025). Jto Clinical And Research Reports. 2025; 6(7)DOI:10.1016/j.jtocrr.2025.100842. PMID:40534993. IF:(Q/D).

Pietrantonio, F, Salvatore, L, Esaki, T, Modest, DP, Lopez-Bravo, DP, Taieb, J, Karamouzis, MV, Ruiz-Garcia, E, Kim, TW, Kuboki, Y, Meriggi, F, Cunningham, D, Yeh, KH, Chan, EMY, Chao, JS, Tran, Q, Cremolini, C, Fakih, M. Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(19)DOI:10.1200/JCO-24-02026. PMID:40215429. IF:41.900(Q1/1D).

Bergmann, L, Albiges, L, Ahrens, M, Gross-Goupil, M, Boleti, E, Gravis, G, Flechon, A, Grimm, MO, Bedke, J, Barthélémy, P, Castellano, D, Mellado, B, Ivanyi, P, Rottey, S, Flörcken, A, Suarez, C, Maroto, P, Grünwald, V, Oosting, SF, Kopecky, J, Zschäbitz, S, Boegemann, M, Buchler, T, Niegisch, G, Goebell, PJ, Waddell, T, Joly, F, Priou, F, Retz, M, Siemer, S, Zimmermann, U, Deckbar, D, Burkholder, I, Hartmann, A, Haanen, JB. Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial. ANNALS OF ONCOLOGY. 2025; 36(7)DOI:10.1016/j.annonc.2025.03.016. PMID:40180121. IF:65.400(Q1/1D).

Da Silva, IM, Riera, P, Bernal, S, Manrique, ACV, Cullell, BM, Paez, D. Relevance of ABCG2 and SRPK1 genetic variants in irinotecan-induced severe toxicity. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.05.046. PMID:. IF:65.400(Q1/1D).

Beltran, JS, Serda, PC, Cardozo, AR, Pérez, MAM, Manrique, ACV, Paez, D, Cullell, BM. A retrospective single-center analysis of treatment strategies and real-world outcomes in locally advanced pancreatic cancer. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.05.288. PMID:. IF:65.400(Q1/1D).

Ponce, CG, Méndez, AM, Plazas, JG, Benavente, MDL, Serda, PC, Vazquez, EB, Conesa, MADLAV, Gil, RHS, Gomez, VL, Alfonso, AL, Custodio-Cabello, S, Paladines, WGP, Carmena, MD, Mercade, TM, Tabares, MLS, Martínez, IP, Gutierrez, LC, Martin, AJM, Fonseca, PJ, Pacheco-Barcia, VE. Prognostic significance of the systemic inflammation response index (SIRI) and nutritional status in metastatic pancreatic cancer: Results from the PANTHEIA-SEOM study. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.05.304. PMID:. IF:65.400(Q1/1D).

Pacheco-Barcia, VE, Méndez, AM, Plazas, JG, Rus, ND, Benavente, MDL, Cullell, BM, Gomez, VL, Vazquez, EB, Conesa, MADLAV, Fernandez, SP, Alfonso, AL, Castet, F, Adeva, JA, Fabregat, C, Abad, DG, Contreras, PZ, Carmona-Bayonas, A, Fonseca, PJ, Gutierrez, LC, Martin, AJM. Impact of the systemic inflammation index (SIRI) and artificial intelligence(AI)-based muscle mass (FocusedON® software) on chemotherapy toxicity and prognosis in metastatic pancreatic cancer: A proof-of-concept from the PANTHEIA-Spanish Society of Medical Oncology (SEOM) study group. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.05.305. PMID:. IF:65.400(Q1/1D).

Rubio, MA, Cisa-Wieczorek, S, Mozos, A, Castellet, H, Bussaglia, E, Carricondo, M, Hernández-Alvarez, MI, Sierra, J, Nomdedéu, JF. SGK1 repression by WT1 may confer a survival advantage to leukemic cells under stress conditions. ANNALS OF HEMATOLOGY. 2025; 104(7)DOI:10.1007/s00277-025-06458-z. PMID:40613901. IF:2.400(Q2/5D).

Moreno, DF, Oriol, A, de la Rubia, J, Hernández, MT, Iñigo, MB, Palomera, L, de Arriba, F, González, Y, Teruel, AI, Pardo, JL, de la Guía, AL, Sampol, A, Ríos-Tamayo, R, Sureda, A, Gutiérrez, NC, Calasanz, MJ, Ramos, MLM, Mateos, MV, San Miguel, J, Lahuerta, JJ, Bladé, J, Rosiñol, L. Is t(11;14) Always aStandard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Trials. Clinical Lymphoma Myeloma & Leukemia. 2025; 25(7)DOI:10.1016/j.clml.2025.01.014. PMID:39955256. IF:2.700(Q2/4D).

Giménez, S, Vaqué-Alcázar, L, Zhu, NL, Benejam, B, Arranz, J, Maure-Blesa, L, Videla, L, Carmona-Iragui, M, Barroeta, I, Rebillat, AS, Rodriguez-Baz, I, Bejanin, A, Arriola-Infante, JE, Bueno, A, Fernandez, S, Ribas, L, Zsadanyi, SE, Morcillo-Nieto, AO, Alcolea, D, Lisgaras, CP, Blessing, E, Osorio, RS, Lleo, A, Fortea, J. Impact of Alzheimer's disease on sleep in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70400. PMID:40604343. IF:11.100(Q1/1D).

Betancor, D, Olaguibel, JM, del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cardaba, B, Cañas, JA, Domínguez-Ortega, J, Cruz, MJ, Curto, E, Garcia de la Fuente, A, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza, V, Quirce, S, Rial, MJ, Soto-Retes, L, Valverde-Monge, M, Mahíllo-Fernández, I, Sastre, J. FEV1Q as a Predictive Metric for Asthma Outcomes. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(7)DOI:10.1016/j.arbres.2025.02.011. PMID:40087119. IF:9.200(Q1/1D).

Almonacid C, Blanco M, Ferreira J, García G, Morete A, Quirce S, Soto-Campos G, Plaza V. Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).. Open Respiratory Archives. 2025; 7(3)DOI:10.1016/j.opresp.2025.100453. PMID:40677934. IF:(Q/D).

Falgas, N, Maure-Blesa, L, Ances, B, Flores-Aguilar, L, Hartley, S, Hassenstab, J, Iulita, MF, Janicki, M, Koenig, K, Lao, PT, Levin, J, McDade, E, Meijer, L, Rafii, MS, Snyder, HM, Sanchez-Valle, R, Fortea, J, Infante, JA, Balasa, M, Barroeta, I, Barthelemy, RN, Bejanin, A, Benejam, B, Bosch, B, Bradshaw, A, Carmona-Iragui, M, Cohen, A, Alberti, AC, Csincsik, L, Cuello, AC, Soriano, LD, Dijkstra, J, Edwards, N, Gimenez, S, Gonzalez-Ortiz, F, Gordon, B, Fernandez, SG, Handen, B, Jacob, C, Johnson, E, Johansson, C, Llado, A, Lleo, A, Morabito, S, Morcillo-Nieto, AO, Montoliu-Gaya, L, Okafor, M, Perez-Millan, A, Potier, MC, Ringman, J, Rodriguez-Baz, I, Rubenstein, E, Ryan, NS, Strydom, A, Vaque-Alcazar, L, Vermunt, L, Toro, LV, Zaman, S. Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70309. PMID:40604347. IF:11.100(Q1/1D).

Fernández Alonso, C., Puig Campmany M., Aguiló Mir, S, Rodríguez Miranda, B, López Díez, M.P., Capilla Pueyo, R., Ferré Losa, C, Mir Montero, M, Arnau Barrés, I, Ruíz Grinspan, M, Martín Mojarro, E, Álvarez Rodríguez, E, Sousa Ávila, Y, Piñera Salmerón, P, Liñán López, M, Martín-Sánchez, FJ, Castejón Hernández, S, González-Armengol, JJ, Del Arco Galán, C. Recomendaciones del Grupo de Trabajo sobre Medicina Geriátrica de Urgencias de la Sociedad Española de Medicina de Urgencias y Emergencias sobre el cribado de fragilidad, valoración geriátrica e intervención en el Servicio de Urgencias (Recomendaciones GEM-SEMES). Revista Española de Urgencias y Emergencias. 2025; 4(3)DOI:10.55633/s3me/REUE021.2025. PMID:. IF:(Q/D).

Lisgaras, CP, Giménez, S, Carmona-Iragui, M, Maure-Blesa, L, Blessing, E, Fortea, J, Osorio, RS. High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70386. PMID:40642994. IF:11.100(Q1/1D).